Global Contraceptive Drugs Market - 2023-2030

Market Overview

The global contraceptives drugs market reached US$ 13.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 22.4 billion by 2030. The global contraceptives drugs market is expected to exhibit a CAGR of 6.6% during the forecast period (2023-2030).

Contraception usage minimises the need for abortion by avoiding undesired pregnancies. As a result, it minimises incidences of unsafe abortion, which is one of the main causes of maternal mortality globally. Contraception is critical in lowering mother and infant mortality rates. When pregnancies are planned and spaced adequately, women may get adequate prenatal care, improving their health and the health outcomes for their newborns.

The global contraceptive drugs market is driven by various factors such as the growth in focus on the need for family planning and preventing unwanted pregnancy, the increase in the use of contraception in young women along with the rise in higher educational attainment propels the market growth.

Market Dynamics

Rising Awareness Among Population & Increasing Government Initiatives to Prevent Unwanted Pregnancies

The global population's increasing growth, particularly in developing economies, raises concerns about unwanted pregnancies, abortion risks, and sexual disorders. Government initiatives are being driven to reduce these risks. India committed to providing family planning services to 48 million new users by 2020, while the U.S. established a maternal and infant health initiative to promote contraception use and reduce unwanted pregnancy rates.

Increasing Rate of Unwanted Pregnancies across the Globe

The growing rate of unwanted pregnancies worldwide is a major concern among the population. As per the Centers for Disease Control and Prevention (CDC), 45% of the 6.1 million annual pregnancies in the U.S. are unwanted. Hence, the increasing rate of unintended pregnancies will spur the market growth across the forecast period.

For instance according to who updated factsheets 2023 as of 2019, adolescents aged 15-19 in low- and middle-income countries (LMICs) had an estimated 21 million pregnancies annually, with 50% unintended and 12 million births. 55% of unintended pregnancies result in abortions, which are often unsafe in LMICs.

Adolescent mothers face higher risks of eclampsia, puerperal endometritis, and systemic infections compared to women aged 20-24. Adolescent birth rates for girls aged 10-14 are increasing, with higher rates in sub-Saharan Africa and Latin America and the Caribbean.

Lack of Awareness About Contraception

A lack of awareness regarding contraceptives refers to a condition in which people, groups, or cultures have inadequate or insufficient understanding about various methods of contraception, including its availability, usage, efficacy, and possible advantages. Unintended pregnancies, the spread of sexually transmitted diseases (STIs), and other health complications can result from a lack of understanding.

COVID-19 Impact Analysis

COVID-19 has had a substantial influence on the value of the contraceptive market. During the pandemic, the use of innovative techniques and technology, including as the use of telemedicine and telehealth in contraceptive start and maintenance, became the standard of care. Numerous telehealth methods allow individuals to connect with health care providers via technology. Supporting mobile outreach programmes that distribute a wide choice of contraceptive products in locations where healthcare practitioners are few has boosted the industry's value.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global contraceptives owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global contraceptive drugs market growth over the forecast period.

Segment Analysis

The global contraceptive drugs market is segmented based on type , distribution channel and region.

Oral Contraceptive Pills From By Type Segment Accounted for Approximately 46.3% of the Contraceptives Drugs Market Share

The oral contraceptive pills from by type segment with around 46.3% is expected to dominate during the forecast period. Mechanism of action inovled in oral contraceptive pills is progesterone which is primarily responsible for preventing pregnancy. The main mechanism of action is the prevention of ovulation; they inhibit follicular development and prevent ovulation.

For instance, in Nov 2022, Lupin received FDA clearance to distribute Drospirenone tablets, a generic oral contraceptive pill, in the United States. The FDA has provisionally accepted Drospirenone Tablets' 4 mg strength abbreviated new drug application (ANDA).

Geographical Analysis

North America Accounted for Approximately 37.6% of the Market Share Owing to the Strong Presence of Major Players and Increasing Technological Advancements

North America is estimated to hold about 37.6% of the total market share throughout the forecast period because of favourable FDA approvals, government programmes, a high number of undesired pregnancies, an increase in the frequency of sexually transmitted infections, and other factors.The US government has undertaken various family planning and contraceptive education initiatives, which have increased the sector's income. There are numerous unplanned pregnancies in the United States.

For instance In Oct 2022,Dare Bioscience, a leader in women's health innovation, has been granted an Investigational Device Exemption (IDE) by the FDA to conduct a single-arm, open-label pivotal contraceptive efficacy study of Ovaprene, an investigational hormone-free monthly intravaginal contraceptive. The FDA determined that the company provided sufficient data to support the study, including the results of the postcoital test (PCT) clinical study. PCT clinical trials have been used as a surrogate marker for contraceptive effectiveness.

Competitive Landscape

The major global players in the contraceptives drugs include: Church & Dwight Co Inc, Teva Pharmaceuticals, Merck & Co Inc, Agile Therapeutics, Ansell Ltd, Mayer Laboratories Inc, Veru Inc, Pfizer Inc, Bayer AG, Abbvie Inc and others.

Why Purchase the Report?

• To visualize the global contraceptives drugs market segmentation based on type, distribution channel and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of contraceptives drugs market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global contraceptives drugs report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies